New York, NY // GenomeWeb interviews Perthera CEO Gary Gregory and CMO Mike Pishvaian about the Perthera Platform’s proven results, the capabilities of Perthera’s molecular tumor board, and how precision medicine is changing the landscape of cancer care today.
GenomeWeb: Perthera’s Molecular Tumor Board Improves Patient Outcomes and Overcomes Barriers
AI-enabled precision, speed and scale
Precision oncology and speed to decision, for everyone, at every point of care.
How We Help